Related Experiment Video

Updated: May 5, 2026

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

863

[I. Diagnosis and treatment for hepatoma]

Masaaki Hidaka, Mitsutoshi Takatsuki, Akihiko Soyama

    Gan to Kagaku Ryoho. Cancer & Chemotherapy
    |December 10, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
    09:11

    Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

    Published on: May 24, 2024

    1.7K
    An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
    06:38

    An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

    Published on: September 12, 2019

    8.5K

    Related Experiment Videos

    Last Updated: May 5, 2026

    Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
    09:03

    Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

    Published on: January 26, 2024

    863
    Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
    09:11

    Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

    Published on: May 24, 2024

    1.7K
    An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
    06:38

    An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

    Published on: September 12, 2019

    8.5K

    Related Concept Videos

    Diseases of the Liver and Gallbladder01:26

    Diseases of the Liver and Gallbladder

    2.1K
    Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
    Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
    2.1K
    Hepatitis01:25

    Hepatitis

    86
    Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
    86

    Articles linked to this work by shared authors, journal, and citation graph.

    The usefulness of the surgeon's perception quantified by visual analog scale in predicting postoperative prognosis.

    Surgery·2026

    A Case of Open Cholecystectomy for Acute Cholecystitis in a Patient with an Implanted Left Ventricular Assist Device on the Waiting List for a Deceased Donor Heart Transplantation.

    Surgical case reports·2026

    Endoscopic Transanal Soave Procedure (ETaS) Using a LAPPROTECTOR for Hirschsprung Disease.

    Asian journal of endoscopic surgery·2026

    Tracheostomy after living donor liver transplantation: the incidence, risk factors, and prognostic significance.

    Surgery today·2026

    Hepatic Compartment Syndrome Induced by Subcapsular Hematoma following Percutaneous Transhepatic Gallbladder Drainage: A Case Report.

    Surgical case reports·2026

    Autologous chemically induced liver progenitor cell transplantation ameliorates steatosis and fibrosis in a preclinical miniature pig model of metabolic dysfunction-associated fatty liver disease: A pilot study.

    Cell transplantation·2026

    [HER2-Positive Breast Cancer Brain Metastasis Recurred after Whole-Brain Radiotherapy and Successfully Treated with Trastuzumab Deruxtecan].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026

    [Employment Status Breast Cancer Patients Received Dose-Dense EC (Epirubicin plus Cyclophosphamide) Therapy].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026

    [Outcome of Eight-Year-Experiences of BCG Intravesical Instillation Therapy in Patients with Non-Muscle Invasive Bladder Cancer in Asahikawa Medical University Hospital].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026

    [Cancer Diagnosis Support System Using 3D Image Recognition AI].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026

    [Frontiers in Research, Development, and Clinical Application of AI-SaMDs].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026

    [AI in Cancer Pathology-Present Developments and Future Directions for Treatment Optimization].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026

    Engineering affibody-based biosensing platforms for cancer biomarker detection.

    ADMET & DMPK·2026

    Validation of the International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Cytopathology.

    Cureus·2026

    Rare intrathyroid nodule-like lesions: Two case reports.

    Radiology case reports·2026

    A solitary lytic rib lesion mimicking primary Chest Wall malignancy as the initial presentation of multiple myeloma.

    Oxford medical case reports·2026

    Next-Generation Sequencing (NGS) Utility in Advanced Solid Tumors in Low- and Middle-Income Country (LMIC) Setting.

    Cureus·2026

    Reprogramming of lipid metabolism by PFKL promotes the adaptation of pancreatic ductal adenocarcinoma to glucose deprivation.

    Cellular signalling·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us